German Life Science Industry major MAQUET to Operate from DuBiotech's Nucleotide Complex

MAQUET shares its Middle East office in DuBiotech with its sister company ArjoHuntleigh and its parent company GETINGE. The four-storey AED289-million technology-intensive complex is scheduled for completion in the second quarter of 2009.

The announcement was made at a press conference at Arab Health 2009, the Middle East's largest healthcare industry exhibition and conference. The media briefing was led by Salah Malek, Managing Director, MAQUET Middle East, Michael Rieder, Vice-President, GETINGE Medical Systems, Germany, Marwan Abdulaziz, Director, DuBiotech, and Marco Baccanti, Executive Director, DuBiotech.

Marwan Abdul Aziz, Director of DuBiotech, said:

"The choice of industry majors such as MAQUET ME to operate from the Nucleotide Complex bears testimony to the global reputation of the region's leading life sciences park. We are firm in our commitment to attract more global majors to our cluster as part of our sincere endeavour to augment the region's biotechnology industry."

MAQUET, based in Rastatt, Germany, is a global market leader in medical systems focused on the Operating Room (OR) and Intensive Care Unit (ICU). The company posted a turnover of around €900 million in 2008. MAQUET currently employs over 4,000 people worldwide and operates in more than 30 countries, with facilities and sales offices supported by a further 200 distributors and partner companies. Its manufacturing centres of excellence are located in Germany, France, China and Sweden.

Salah Malek, Managing Director, Maquet ME, said: "MAQUET's success in the Middle East has translated into our decision to have a state of the art training facility at the DuBiotech laboratory complex. Our facility will house virtual operating room systems and intensive care units.

"MAQUET continues to lead the competition by investing in research and development to provide long-term value and define the best medical technology in the market. With our investments in hospitals as best in class reference sites to increase the standard of patient care, MAQUET has positioned itself as partners to healthcare providers in Dubai and the Middle East."

With the Regional Sales Office in Dubai, MAQUET is making a sustained commitment to the Middle East region. The six Gulf states as well as Iran, Yemen and Egypt, are ranked among the fastest growing healthcare markets with the best clinical experts and considerable advancement in medical technology.

Designed by CUH2A, a recognised leader in creating facilities for science and technology institutions, the Nucleotide Complex will feature accredited diagnostic and analysis laboratories which comply with international ISO standards. Comprising 'A, C, T and G' wings, the facility has been named after the four basic building blocks of nucleic acids, the main components of genetic material.

Dubai Biotechnology and Research Park (DuBiotech) is dedicated to creating an advanced technical and community infrastructure to accelerate the growth of life sciences industry. It is also working closely with the UAE Ministry of Health, the Dubai Health Authority, and other relevant regulatory bodies to further develop the industry in the country and the region.